Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD

Inflammatory Bowel Diseases

Volumn 11, Issue 5, 2005, Pages 473-480

  Lepage, Patricia ^a   Seksik, Philippe ^a,b   Sutren, Malène ^a   de la Cochetière, Marie France ^c   Jian, Raymond ^b   Marteau, Philippe ^b   Doré, Joël ^a  

^a CEMAGREF   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

16S ribosomal DNA; Inflammatory bowel disease; Intestinal microbiota; Mucosa associated microbiota; Temporal temperature gradient gel electrophoresis

Indexed keywords

BACTERIAL DNA; DNA 16S;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON FLORA; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FECES MICROFLORA; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; ILEUM MUCOSA; INTESTINE FLORA; INTESTINE MUCOSA; MALE; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; RECTUM MUCOSA; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DNA, BACTERIAL; DNA, RIBOSOMAL; ENTEROBACTERIACEAE; FECES; FEMALE; HUMANS; ILEUM; INTESTINAL MUCOSA; INTESTINE, LARGE; MALE; MIDDLE AGED;

EID: 18944401261     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000159662.62651.06     Document Type: Article

References (47)

1. Marteau P, Seksik P, Shanahan F. Manipulation of the bacterial flora in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2003; 17:47-61.
2. Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut. 2001;48:132-135.
3. Duchmann R, Neurath M, Marker-Hermann E, et al. Immune responses towards intestinal bacteria - current concepts and future perspectives. Z Gastroenterol. 1997;35:337-346.
4. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102:448-455.
5. Blaut M, Collins MD, Welling GW, et al. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr. 2002;87(Suppl 2):S203-S211.
6. Sghir A, Gramet G, Suau A, et al. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol. 2000;66:2263-2266.
7. Dore J, Sghir A, Hannequart-Gramet G, et al. Design and evaluation of a 16S rRNA-targeted oligonucleotide probe for specific detection and quantitation of human faecal Bacteroides populations. Syst Appl Microbiol. 1998;21:65-71.
8. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999;65:4799-4807.
9. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991;338:771-774.
10. Harper PH, Lee EC, Kettlewell MG, et al. Role of the faecal stream in the maintenance of Crohn's colitis. Gut. 1985; 26:279-284.
11. Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 1999;67:2969-2974.
12. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66:5224-5231.
13. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol. 1997;148:567-576.
14. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344-1367.
15. Ehrhardt RO, Ludviksson BR, Gray B, et al. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol. 1997;158: 566-573.
16. Onderdonk AB, Richardson JA, Hammer RE, et al. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun. 1998;66:6022-6023.
17. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359-2364.
18. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229-241.
19. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52:237-242.
20. Giaffer MR, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol. 1991;35:238-243.
21. Ruseler-van Embden JG, Both-Patoir HC. Anaerobic grain-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek. 1983;49:125-132.
22. Keighley MR, Arabi Y, Dimock F, et al. Influence of inflammatory bowel disease on intestinal microflora. Gut. 1978;19:1099-1104.
23. Mangin I, Bonnet R, Seksik P, et al. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol. 2004;50:25-36.
24. Zoetendal EG, von Wright A, Vilpponen-Salmela T, et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68:3401-3407.
25. Biancone L, Monteleone I, Del Vecchio Blanco G, et al. Resident bacterial flora and immune system. Dig Liver Dis. 2002;34(Suppl 2):S37-S43.
26. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405-1413.
27. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol. 2002;292:185-193.
28. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93.
29. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
30. Rayment N, Mylonaki M, Hudspith B, et al. Reduced bifidobacteria and increase E. coli in rectal mucosa-associated flora in active inflammatory bowel disease. Gut. 2002;50:A29.
31. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
32. Macfarlane S, Furrie E, Cummings JH, et al. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis. 2004;38:1690-1699.
33. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979;77:843-846.
34. Sutherland LR, Martin F. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada. Dig Dis Sci. 1987;32:64S-66S.
35. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 1998;64:3854-3859.
36. Gérard P, Béguet F, Lepercq P, et al. Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion. FEMS Microbiol Ecol. 2004;47:337-343.
37. Schultsz C, Van Den Berg FM, Ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999;117:1089-1097.
38. He F, Ouwehand AC, Isolauri E, et al. Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol. 2001;43:351-354.
39. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001;48: 198-205.
40. Saunier K, Dore J. Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis. 2002;34(Suppl 2):S19-S24.
41. Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care. 2003;6:49-54.
42. Marteau P, Lepage P, Mangin I, et al. Gut flora and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):18-23.
43. Marteau P, Pochart P, Dore J, et al. Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol. 2001;67:4939-4942.
44. Pochart P, Lemann F, Flourie B, et al. Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans. Gastroenterology. 1993;105:1281-1285.
45. Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl. 2001;234:29-40.
46. Hartley MG, Hudson MJ, Swarbrick ET, et al. The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol. 1992;36:96-103.
47. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4.